The current rush to approve medicines while manufacturers' "patent clocks" are ticking means that some medicines make it to market that later must be recalled because of harms they cause to patients -- harms that could be detected with more thorough pre-market evaluation.
OTTAWA - As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of wha...
OTTAWA — As trade talks with Europe enter the final stretch, Canada's patent drug industry is making a final push to sell their brand of medicine to...